Quantinno Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quantinno Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.2M	Buy	37,108 +3,258	+10%	+$983K	0.01%	937
2026 Q1	$11.2M	Buy	33,850 +8,258	+32%	+$2.81M	0.02%	830
2025 Q4	$10.2M	Buy	25,592 +6,327	+33%	+$2.8M	0.02%	773
2025 Q3	$8.79M	Buy	19,265 +5,801	+43%	+$2.36M	0.02%	712
2025 Q2	$4.39M	Buy	13,464 +7,032	+109%	+$1.95M	0.02%	859
2025 Q1	$1.74M	Buy	6,432 +1,876	+41%	+$482K	0.01%	1015
2024 Q4	$1.07M	Buy	4,556 +1,190	+35%	+$313K	0.01%	1034
2024 Q3	$926K	Buy	3,366 +1,126	+50%	+$293K	0.01%	962
2024 Q2	$544K	Buy	+2,240	New	+$354K	0.01%	1010

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantinno Capital Management's ALNY Position: Q2 2026 in Review

Quantinno Capital Management increased its Alnylam Pharmaceuticals (ALNY) stake by 9.6% in Q2 2026, buying an estimated $983K and bringing the position to 37,108 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #937.

Quantinno Capital Management first reported a position in ALNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.2M in Q1 2026. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Quantinno Capital Management held 37,108 shares of Alnylam Pharmaceuticals worth $11.2M as of Q2 2026.
Quantinno Capital Management bought 3,258 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $983K.
Alnylam Pharmaceuticals made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #937 holding.
Quantinno Capital Management first reported a position in Alnylam Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Quantinno Capital Management's Alnylam Pharmaceuticals position peaked at $11.2M in Q1 2026.
791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.